Skip to main content

AGILYSYS INC

For the period ended Dec 31, 2023. Filed Jan 25, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Jan 25, 2024

AGYS$124.15+0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)December 31, 2023 (Unaudited)March 31,2023
ASSETS
Current assets:
Cash and cash equivalents$116,200$112,842
Accounts receivable, net of allowance for expected credit losses of $763 and $610, respectively49,36622,378
Contract assets1,9712,242
Inventories6,7729,774
Prepaid expenses and other current assets9,3857,422
Total current assets183,694154,658
Property and equipment, net18,07414,576
Operating lease right-of-use assets18,73412,708
Goodwill33,08232,638
Intangible assets, net17,22318,140
Deferred income taxes, non-current67,9992,790
Other non-current assets7,8527,526
Total assets$346,658$243,036
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable$9,012$9,418
Contract liabilities62,93852,124
Accrued liabilities15,31013,708
Operating lease liabilities, current3,9473,263
Finance lease obligations, current—2
Total current liabilities91,20778,515
Deferred income taxes, non-current1,0352,257
Operating lease liabilities, non-current20,20013,477
Other non-current liabilities3,9434,018
Commitments and contingencies
Series A convertible preferred stock, no par value—35,459
Shareholders' equity:
Common shares, without par value, at $0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 27,349,322 and 25,326,626 shares outstanding at December 31, 2023 and March 31, 2023, respectively10,0039,482
Treasury shares, 5,992,966 and 6,280,205 at December 31, 2023 and March 31, 2023, respectively(1,798)(1,884)
Capital in excess of stated value91,17352,978
Retained earnings134,79452,764
Accumulated other comprehensive loss(3,899)(4,030)
Total shareholders' equity230,273109,310
Total liabilities and shareholders' equity$346,658$243,036

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three months endedDecember 31,Nine months endedDecember 31,
(In thousands, except per share data)2023202220232022
Net revenue:
Products$12,678$10,697$38,100$32,291
Subscription and maintenance35,10730,154101,48186,917
Professional services12,7819,06935,66225,960
Total net revenue60,56649,920175,243145,168
Cost of goods sold:
Products6,7075,36820,02316,682
Subscription and maintenance7,3716,76722,81219,223
Professional services8,6647,00926,42820,627
Total cost of goods sold22,74219,14469,26356,532
Gross profit37,82430,776105,98088,636
Gross profit margin62.5%61.7%60.5%61.1%
Operating expenses:
Product development14,55112,41642,45536,550
Sales and marketing6,1375,88619,83816,619
General and administrative9,0577,92827,20722,850
Depreciation of fixed assets9094373,0421,371
Amortization of internal-use software and intangibles3434301,1201,326
Other (gains) and charges, net(924)9345374
Legal settlements—104—104
Total operating expense30,07327,29493,70779,194
Operating income7,7513,48212,2739,442
Other income (expense):
Interest income1,2527043,5801,186
Other income (expense), net95384(15)799
Income before taxes9,0984,57015,83811,427
Income tax (benefit) provision(68,043)678(67,396)920
Net income$77,141$3,892$83,234$10,507
Series A convertible preferred stock dividends(286)(459)(1,204)(1,377)
Net income attributable to common shareholders$76,855$3,433$82,030$9,130
Weighted average shares outstanding - basic25,80824,70325,25624,651
Net income per share - basic:$2.98$0.14$3.25$0.37
Weighted average shares outstanding - diluted26,97926,07026,46325,780
Net income per share - diluted:$2.85$0.13$3.10$0.35

CONDENSED CONSOLIDATED STATE MENTS OF COMPREHENSIVE INCOME

Three months endedDecember 31,Nine months endedDecember 31,
(In thousands)2023202220232022
Net income77,141$3,89283,234$10,507
Other comprehensive income (loss), net of tax:
Unrealized foreign currency translation adjustments187(248)131(902)
Total comprehensive income$77,328$3,644$83,365$9,605

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Nine Months Ended
December 31,
(In thousands)20232022
Operating activities
Net income$83,234$10,507
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on asset disposals(1,145)—
Depreciation of fixed assets3,0421,371
Amortization of internal-use software and intangibles1,1201,326
Deferred income taxes(66,506)(378)
Share-based compensation9,4899,410
Changes in operating assets and liabilities(10,855)(4,556)
Net cash provided by operating activities18,37917,680
Investing activities
Capital expenditures(7,658)(3,616)
Additional investments in corporate-owned life insurance policies(2)(27)
Net cash used in investing activities(7,660)(3,643)
Financing activities
Payment of preferred stock dividends(1,663)(1,836)
Repurchase of common shares to satisfy employee tax withholding(5,734)(2,924)
Principal payments under long-term obligations(2)(3)
Net cash used in financing activities(7,399)(4,763)
Effect of exchange rate changes on cash38(427)
Net increase in cash and cash equivalents3,3588,847
Cash and cash equivalents at beginning of period112,84296,971
Cash and cash equivalents at end of period$116,200$105,818

CONDENSED CONSOLIDATED STATEM ENTS OF SHAREHOLDERS' EQUITY

Common Shares · Capital in · Accumulated
Issued · In Treasury · excess of · other
(In thousands, except share data)SharesStatedvalueSharesStatedvalueStatedvalueRetainedearningscomprehensiveincome (loss)Total
Balance at September 30, 202331,607$9,482(6,236)$(1,871)$55,154$57,939$(4,086)$116,618
Share-based compensation————3,488——3,488
Restricted shares issued, net——17352(52)———
Shares issued upon exercise of SSARs——9328(28)———
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares——(22)(7)(1,868)——(1,875)
Net income—————77,141—77,141
Conversion of Series A preferred stock1,735521——34,479——35,000
Series A convertible preferred stock dividends—————(286)—(286)
Unrealized translation adjustments——————187187
Balance at December 31, 202333,342$10,003(5,992)$(1,798)$91,173$134,794$(3,899)$230,273
Common Shares · Capital in · Accumulated
Issued · In Treasury · excess of · other
(In thousands, except share data)SharesStatedvalueSharesStatedvalueStatedvalueRetainedearningscomprehensiveincome (loss)Total
Balance at September 30, 202231,607$9,482(6,550)$(1,965)$54,072$45,715$(710)$106,594
Share-based compensation————3,323——3,323
Restricted shares issued, net——8626(26)———
Shares issued upon exercise of SSARs——5818(18)———
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares——(16)(5)(1,185)——(1,190)
Net income—————3,892—3,892
Series A convertible preferred stock dividends—————(459)—(459)
Unrealized translation adjustments——————(248)(248)
Balance at December, 202231,607$9,482(6,422)$(1,926)$56,166$49,148$(958)$111,912
Common Shares · Capital in · Accumulated
Issued · In Treasury · excess of · other
(In thousands, except share data)SharesStatedvalueSharesStatedvalueStatedvalueRetainedearningscomprehensiveincome (loss)Total
Balance at March 31, 202331,607$9,482(6,280)$(1,884)$52,978$52,764$(4,030)$109,310
Share-based compensation————9,399——9,399
Restricted shares issued, net——17753(53)———
Shares issued upon exercise of SSARs——18355(55)———
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares——(72)(22)(5,575)——(5,597)
Net income—————83,234—83,234
Conversion of Series A preferred stock1,735521——34,479——35,000
Series A convertible preferred stock dividends—————(1,204)—(1,204)
Unrealized translation adjustments——————131131
Balance at December 31, 202333,342$10,003(5,992)$(1,798)$91,173$134,794$(3,899)$230,273
Common Shares · Capital in · Accumulated
Issued · In Treasury · excess of · other
(In thousands, except share data)SharesStatedvalueSharesStatedvalueStatedvalueRetainedearningscomprehensiveincome (loss)Total
Balance at March 31, 202231,607$9,482(6,879)$(2,063)$49,963$40,018$(56)$97,344
Share-based compensation————9,342——9,342
Restricted shares issued, net——33199(99)———
Shares issued upon exercise of SSARs——18155(55)———
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares——(55)(17)(2,985)——(3,002)
Net income—————10,507—10,507
Series A convertible preferred stock dividends—————(1,377)—(1,377)
Unrealized translation adjustments——————(902)(902)
Balance at December, 202231,607$9,482(6,422)$(1,926)$56,166$49,148$(958)$111,912
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.